Stay updated on Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial

Sign up to get notified when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Revision history updated: added Revision: v3.4.3 and removed Revision: v3.4.2.
    Difference
    0.1%
    Check dated 2026-03-11T17:41:31.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    Revision: v3.4.2 added; the government funding lapse notice and Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:25:21.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    A government funding notice about site operation status was added, and the page revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-03T23:36:00.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Added Show glossary and updated metadata: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. Removed Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4.
    Difference
    0.2%
    Check dated 2026-01-27T21:33:26.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Added a dedicated Locations section and explicitly listed Ohio as a study site; removed the older Ohio Locations item and the HHS Vulnerability Disclosure link, and updated the revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T09:11:05.000Z thumbnail image
  8. Check
    105 days ago
    Change Detected
    Summary
    Footer revision label updated from v3.3.1 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T16:39:00.000Z thumbnail image

Stay in the know with updates to Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Lenalidomide Nivolumab Combo in Relapsed Myeloma Clinical Trial page.